GB Magazine February 2023 | Page 44

Science

Curebound ACCELERATING CANCER RESEARCH INTO CURES

Cures in our Lifetime
Cures in our Lifetime
Curebound unites San Diego ’ s top research institutions in a collaborative effort to accelerate cancer research into cures . Founded upon a deeply held belief that cures are possible , Curebound ’ s unique platform and funding model fosters collaboration and cooperation , bringing the best minds together to take on cancer ’ s greatest challenges . With over $ 23 million already invested in research , Curebound has awarded 90 diverse research grants and clinical trials to explore all types of adult and pediatric cancers .
With 1 in 2 men and 1 in 3 women expected to be diagnosed with cancer , Curebound ’ s mission is to mobilize San Diego to accelerate cures for cancer in our lifetime .
Cancer Curing City
Curebound is headquartered here in San Diego , a top-three city for biotech development and home to a unique combination of NCI-cancer centers , clinical care hospitals , research institutions and life science companies . This ecosystem positions San Diego at the forefront of discovery - bringing genomic medicine , new technologies and clinical trials to market . Curebound is the catalyst to bring these resources together to drive the work faster and further - to expedite discovery and improve the lives of patients today .
World Class Collaboration
Curebound ’ s cutting-edge collaborative approach assembles the best scientists from San Diego ’ s leading research organizations including Moores Cancer Center , Salk Institute , Rady Children ’ s Hospital , Sanford Burnham Prebys , La Jolla Institute for Immunology and Scripps Research . Guided by its ’ world class
44 GBSAN . COM | FEBRUARY 2023